Cargando…
Reclassification of interval cancers and implications for disclosure of audit
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300421/ http://dx.doi.org/10.1186/bcr880 |
| _version_ | 1782226275165798400 |
|---|---|
| author | Turnbull, AE Bagnall, MJC |
| author_facet | Turnbull, AE Bagnall, MJC |
| author_sort | Turnbull, AE |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3300421 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2004 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-33004212012-03-14 Reclassification of interval cancers and implications for disclosure of audit Turnbull, AE Bagnall, MJC Breast Cancer Res Poster Presentation BioMed Central 2004 2004-07-14 /pmc/articles/PMC3300421/ http://dx.doi.org/10.1186/bcr880 Text en |
| spellingShingle | Poster Presentation Turnbull, AE Bagnall, MJC Reclassification of interval cancers and implications for disclosure of audit |
| title | Reclassification of interval cancers and implications for disclosure of audit |
| title_full | Reclassification of interval cancers and implications for disclosure of audit |
| title_fullStr | Reclassification of interval cancers and implications for disclosure of audit |
| title_full_unstemmed | Reclassification of interval cancers and implications for disclosure of audit |
| title_short | Reclassification of interval cancers and implications for disclosure of audit |
| title_sort | reclassification of interval cancers and implications for disclosure of audit |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300421/ http://dx.doi.org/10.1186/bcr880 |
| work_keys_str_mv | AT turnbullae reclassificationofintervalcancersandimplicationsfordisclosureofaudit AT bagnallmjc reclassificationofintervalcancersandimplicationsfordisclosureofaudit |